跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 72 条关于
“PAX3::FOXO1”
全部
72
临床试验
44
药物
17
机构
1
资讯
10
3个月前
Advancing Pediatric Rhabdomyosarcoma Therapeutics: FGFR4, MYOD1, and Novel Degrader Strategies Take Center Stage
上个月
Post-translational modifications orchestrate CD8+ T cell exhaustion from signal initiation to epigenetic locking
去年
IPF Drug Development Heats Up with Novel Targets and Clinical Advances
12天前
Louisiana Family Rallies Support for FoxP1 Syndrome Gene Therapy Research
去年
University at Buffalo Opens FOXG1 Research Center to Advance Gene Therapy for Rare Disorder
7个月前
FDA Clears First FOXG1 Gene Therapy for Clinical Trials in Rare Neurodevelopmental Disorder
9个月前
PAXG Chemotherapy Shows Superior Event-Free Survival Over mFOLFIRINOX in Pancreatic Cancer Trial
10个月前
CASSANDRA Phase 3 Trial Shows PAXG Superior to mFOLFIRINOX in Preoperative Pancreatic Cancer Treatment
7个月前
FDA Approves Optune Pax for Locally Advanced Pancreatic Cancer, First New Treatment in Nearly 30 Years
7个月前
FDA Approves NovoCure's Optune Pax for Locally Advanced Pancreatic Cancer, First New Treatment in Nearly 30 Years